These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resection. Uen YH; Lu CY; Tsai HL; Yu FJ; Huang MY; Cheng TL; Lin SR; Wang JY Ann Surg Oncol; 2008 Aug; 15(8):2120-8. PubMed ID: 18481151 [TBL] [Abstract][Full Text] [Related]
43. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379 [TBL] [Abstract][Full Text] [Related]
44. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma. Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072 [TBL] [Abstract][Full Text] [Related]
45. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844 [TBL] [Abstract][Full Text] [Related]
46. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma. Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991 [TBL] [Abstract][Full Text] [Related]
47. Mechanisms of oncogenesis in colon versus rectal cancer. Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095 [TBL] [Abstract][Full Text] [Related]
48. Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma. Garnier JP; Letellier S; Cassinat B; Lebbé C; Kerob D; Baccard M; Morel P; Basset-Seguin N; Dubertret L; Bousquet B; Stoitchkov K; Le Bricon T Eur J Cancer; 2007 Mar; 43(4):816-21. PubMed ID: 17276671 [TBL] [Abstract][Full Text] [Related]
49. A study of the expression of Cyclin E and its isoforms in tumor and adjacent mucosa, correlated to patient outcome in early colon cancer. Corin I; Larsson L; Bergström J; Gustavsson B; Derwinger K Acta Oncol; 2010; 49(1):63-9. PubMed ID: 20001501 [TBL] [Abstract][Full Text] [Related]
50. Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse. Lu CY; Uen YH; Tsai HL; Chuang SC; Hou MF; Wu DC; Juo SH; Lin SR; Wang JY Br J Cancer; 2011 Mar; 104(7):1178-84. PubMed ID: 21343933 [TBL] [Abstract][Full Text] [Related]
51. Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer. Kersten C; Louhimo J; Ålgars A; Lahdesmaki A; Cvancerova M; Stenstedt K; Haglund C; Gunnarsson U Acta Oncol; 2013 Nov; 52(8):1691-8. PubMed ID: 24102179 [TBL] [Abstract][Full Text] [Related]
52. Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer. Okuyama T; Sameshima S; Takeshita E; Mitsui T; Noro T; Ono Y; Noie T; Ban S; Oya M BMC Cancer; 2020 Sep; 20(1):842. PubMed ID: 32883261 [TBL] [Abstract][Full Text] [Related]
53. Clinical Impact of Postoperative Vitamin D Deficiency on the Recurrence of Colon Cancer After Curative Surgical Resection. Kim J; Baek DW; Baek JH; Kang BW; Song SH; Kim HJ; Park SY; Park JS; Choi GS; Kim JG Anticancer Res; 2021 Jul; 41(7):3683-3688. PubMed ID: 34230167 [TBL] [Abstract][Full Text] [Related]
54. Development and progression of malignancy in human colon tissues are correlated with expression of specific Ca(2+)-binding S100 proteins. Bronckart Y; Decaestecker C; Nagy N; Harper L; Schäfer BW; Salmon I; Pochet R; Kiss R; Heizman CW Histol Histopathol; 2001 Jul; 16(3):707-12. PubMed ID: 11510959 [TBL] [Abstract][Full Text] [Related]
55. Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients. Giampieri R; Scartozzi M; Loretelli C; Piva F; Mandolesi A; Lezoche G; Del Prete M; Bittoni A; Faloppi L; Bianconi M; Cecchini L; Guerrieri M; Bearzi I; Cascinu S PLoS One; 2013; 8(9):e72843. PubMed ID: 24023782 [TBL] [Abstract][Full Text] [Related]
56. Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I-III colon cancer. Zhang Z; Feng Q; Jia C; Zheng P; Lv Y; Mao Y; Xu Y; He G; Xu J Genomics; 2020 Nov; 112(6):4032-4040. PubMed ID: 32645524 [TBL] [Abstract][Full Text] [Related]
57. Is a less-intensive follow-up for colon cancer in early stages reasonable? Esswein K; Volpi M; Ninkovic M; Kröpfl V; Gasser E; Lorenz A; Stecher L; Kafka-Ritsch R; Schneeberger S; Öfner D; Perathoner A Int J Colorectal Dis; 2023 Mar; 38(1):60. PubMed ID: 36869966 [TBL] [Abstract][Full Text] [Related]